Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Total Liabilities (2016 - 2025)

Veracyte's Total Liabilities history spans 14 years, with the latest figure at $96.4 million for Q4 2025.

  • For Q4 2025, Total Liabilities fell 22.27% year-over-year to $96.4 million; the TTM value through Dec 2025 reached $96.4 million, down 22.27%, while the annual FY2025 figure was $96.4 million, 22.27% down from the prior year.
  • Total Liabilities for Q4 2025 was $96.4 million at Veracyte, down from $110.1 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $124.1 million in Q4 2024 and bottomed at $50.9 million in Q1 2021.
  • The 5-year median for Total Liabilities is $81.3 million (2022), against an average of $87.9 million.
  • The largest annual shift saw Total Liabilities skyrocketed 154.13% in 2021 before it dropped 22.27% in 2025.
  • A 5-year view of Total Liabilities shows it stood at $91.3 million in 2021, then fell by 11.05% to $81.2 million in 2022, then dropped by 12.83% to $70.8 million in 2023, then soared by 75.23% to $124.1 million in 2024, then dropped by 22.27% to $96.4 million in 2025.
  • Per Business Quant, the three most recent readings for VCYT's Total Liabilities are $96.4 million (Q4 2025), $110.1 million (Q3 2025), and $123.0 million (Q2 2025).